- Home
- RDW vs VRDN Comparison
RDW vs VRDN Comparison
Compare RDW & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDW
- VRDN
- Stock Information
- Founded
- RDW 2020
- VRDN 2006
- Country
- RDW United States
- VRDN United States
- Employees
- RDW N/A
- VRDN N/A
- Industry
- RDW Military/Government/Technical
- VRDN Medical Specialities
- Sector
- RDW Industrials
- VRDN Health Care
- Exchange
- RDW Nasdaq
- VRDN Nasdaq
- Market Cap
- RDW 1.5B
- VRDN 1.6B
- IPO Year
- RDW N/A
- VRDN N/A
- Fundamental
- Price
- RDW $10.11
- VRDN $13.13
- Analyst Decision
- RDW Strong Buy
- VRDN Buy
- Analyst Count
- RDW 6
- VRDN 12
- Target Price
- RDW $17.71
- VRDN $36.44
- AVG Volume (30 Days)
- RDW 1.8M
- VRDN 1.2M
- Earning Date
- RDW 05-07-2025
- VRDN 05-07-2025
- Dividend Yield
- RDW N/A
- VRDN N/A
- EPS Growth
- RDW N/A
- VRDN N/A
- EPS
- RDW N/A
- VRDN N/A
- Revenue
- RDW $304,101,000.00
- VRDN $302,000.00
- Revenue This Year
- RDW $58.76
- VRDN N/A
- Revenue Next Year
- RDW $35.23
- VRDN $20,553.29
- P/E Ratio
- RDW N/A
- VRDN N/A
- Revenue Growth
- RDW 24.73
- VRDN N/A
- 52 Week Low
- RDW $3.39
- VRDN $9.90
- 52 Week High
- RDW $26.66
- VRDN $27.20
- Technical
- Relative Strength Index (RSI)
- RDW 48.12
- VRDN 46.75
- Support Level
- RDW $8.83
- VRDN $9.90
- Resistance Level
- RDW $10.29
- VRDN $14.22
- Average True Range (ATR)
- RDW 1.07
- VRDN 1.17
- MACD
- RDW 0.42
- VRDN 0.18
- Stochastic Oscillator
- RDW 92.59
- VRDN 74.77
About RDW Redwire Corporation
Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's Heritage plus Innovation strategy enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.